ArcBest Corp ARCB NASDAQ · Industrials · United States
$134.58 -0.98% -$1.33
Summary
43 / 100 · Bulios Score
What speaks for it
- Analysts expect revenue to grow by 13% this fiscal year.
- It passes 9 of the 9 points of the Piotroski financial health test.
What to watch
- Earnings per share fell by 39% a year over the last 3 years.
- The share price is above the Bulios Fair Price.
- Out of every 100 USD of revenue, only 0.7 USD is left as net profit.
- It earns only 2.0 USD a year on every 100 USD of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBy our assumptions the business is worth less than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 105.9 USD for 1 USD of yearly profit. Over the last five years it was 15.5 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 6.4% a year over 5 years. Over the last 3 years it fell by 7.3% a year. For the next fiscal year analysts expect revenue to grow by 13%. Earnings per share fell by 39% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 22 USD
- Sales and administration 76 USD
- Taxes and other 0.4 USD
- Net profit 0.7 USD
Net profit, industry median (Trucking) 3.2 USD
Out of every 100 USD of revenue, 0.7 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 1.7 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 0.35%
- Paid out of profit
- 37%
You receive $0.48 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 12
- Hold 11
- Sell 1
Today's price within the analysts' price targets
The average target of $164 is 22% above today's price. 50% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Asset Based Segment 100%
By region
The company reports no revenue by region.
Asset Based Segment brings in 100% of revenue.
Segments in detail